Skip to main content
Home > Week in Review > Sales & Marketing

Chronological Index of : Sales and Marketing

 Current Issue
  • GlaxoSmithKline sales and marketing update

    GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. Business: Endocrine/Metabolic The German Institute for Quality and Efficiency in Health Care (IQWiG) said Tanzeum albiglutide from GlaxoSmithKline in combination …

    Published on 6/8/2015
  • Medivation, Astellas sales and marketing update

    Medivation Inc. (NASDAQ:MDVN), San Francisco, Calif. Astellas Pharma Inc. (Tokyo:4503), Tokyo, Japan Business: Cancer The German Institute for Quality and Efficiency in Health Care (IQWiG) said Xtandi enzalutamide from …

    Published on 6/8/2015
  • PTC sales and marketing update

    PTC Therapeutics Inc. (NASDAQ:PTCT), South Plainfield, N.J. Business: Musculoskeletal PTC said Germanys Federal Joint Committee (G-BA) issued a benefit assessment stating that Translarna ataluren provided a clinically …

    Published on 6/8/2015
  • Regeneron, Bayer sales and marketing update

    Regeneron Pharmaceuticals Inc. (NASDAQ:REGN), Tarrytown, N.Y. Bayer AG (Xetra:BAYN), Leverkusen, Germany Business: Ophthalmic The U.K.s NICE issued a final appraisal determination (FAD) recommending Eylea aflibercept …

    Published on 6/8/2015
  • Santen sales and marketing update

    Santen Pharmaceutical Co. Ltd. (Tokyo:4536), Osaka, Japan Business: Ophthalmic The German Institute for Quality and Efficiency in Health Care (IQWiG) said that added benefit cannot be derived for the fixed combination …

    Published on 6/8/2015
  • Biodesix sales and marketing update

    Biodesix Inc., Broomfield, Colo. Business: Diagnostic Biodesix launched its GeneStrat targeted liquid biopsy mutation test in the U.S. to genotype tumors of patients with advanced non-small cell lung cancer (NSCLC). The…

    Published on 6/1/2015
  • Exact Sciences, Anthem, CareFirst BlueCross BlueShield, Excellus BlueCross BlueShield sales and marketing update

    Exact Sciences Corp. (NASDAQ:EXAS), Madison, Wis. Anthem Inc. (NYSE:ANTM), Indianapolis, Ind. CareFirst BlueCross BlueShield, Baltimore, Md. Excellus BlueCross BlueShield, Rochester, N.Y. Business: Diagnostic Exact …

    Published on 5/25/2015
  • Novocure sales and marketing update

    Novocure Ltd., Isle of Jersey Business: Cancer The National Comprehensive Cancer Network (NCCN) updated its guidelines in oncology to include Optune tumor treating fields (TTFields) delivery device from Novocure to …

    Published on 5/25/2015
  • uniQure sales and marketing update

    uniQure N.V. (NASDAQ:QURE), Amsterdam, the Netherlands Business: Endocrine/Metabolic Germanys Federal Joint Committee (G-BA) issued a final benefit assessment stating that the additional benefit was not quantifiable …

    Published on 5/25/2015
  • Color Genomics sales and marketing update

    Color Genomics Inc., Burlingame, Calif. Business: Genomics Color Genomics launched its genetic sequencing Color Test that analyzes 19 genes known to have an inherited predisposition for breast and ovarian cancer. The …

    Published on 5/18/2015
  • Veracyte sales and marketing update

    Veracyte Inc. (NASDAQ:VCYT), South San Francisco, Calif. Business: Diagnostic Veracyte launched the Percepta Bronchial Genomic Classifier in the U.S. to resolve ambiguity in lung cancer diagnosis. The 23-gene molecular …

    Published on 5/18/2015
  • Celltrion, Hospira, J&J, Merck, Orion sales and marketing update

    Celltrion Inc. (KOSDAQ:068270), Incheon, South Korea Hospira Inc. (NYSE:HSP), Lake Forest, Ill. Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. Merck & Co. Inc. (NYSE:MRK), Whitehouse Station, N.J. Orion Corp. (HSE…

    Published on 5/11/2015
  • Novo Nordisk sales and marketing update

    Novo Nordisk A/S (CSE:NVO; NYSE:NVO), Bagsvaerd, Denmark Business: Hematology Novo Nordisk launched Novoeight turoctocog alfa in the U.S. to treat hemophilia A. The recommended dosage of the third-generation IV …

    Published on 5/11/2015
  • uniQure, Chiesi sales and marketing update

    uniQure N.V. (NASDAQ:QURE), Amsterdam, the Netherlands Chiesi Farmaceutici S.p.A., Parma, Italy Business: Endocrine/Metabolic EMAs Committee for Advanced Therapies (CAT) said it did not agree with a rapporteurs …

    Published on 5/11/2015
  • Viiv Healthcare sales and marketing update

    ViiV Healthcare Ltd., Brentford, U.K. Business: Infectious ViiV announced the launch of Triumeq dolutegravir/abacavir/lamivudine in Japan to treat HIV infection. GlaxoSmithKline plc (LSE:GSK; NYSE:GSK, London, U.K.) …

    Published on 5/11/2015
  • Basilea, Astellas sales and marketing update

    Basilea Pharmaceutica AG (SIX:BSLN), Basel, Switzerland Astellas Pharma Inc. (Tokyo:4503), Tokyo, Japan Business: Infectious Astellas launched Cresemba isavuconazonium in the U.S. to treat invasive aspergillosis and …

    Published on 5/4/2015
  • Courtagen Life Sciences sales and marketing update

    Courtagen Life Sciences Inc., Woburn, Mass. Business: Diagnostic Courtagen launched lysoSEEK, a genetic test that identifies enzymatic deficiencies in 94 genes associated with lysosomal storage disorders from a saliva …

    Published on 5/4/2015
  • Gilead sales and marketing update

    Gilead Sciences Inc. (NASDAQ:GILD), Foster City, Calif. Business: Infectious Gilead said that Harvoni ledipasvir/sofosbuvir will now be reimbursed by provincial drug programs in Canadian provinces and territories, …

    Published on 5/4/2015
  • Intas Pharmaceuticals sales and marketing update

    Intas Pharmaceuticals Ltd., Ahmedabad, India Business: Autoimmune, Biosimilars Intas launched Intacept, a biosimilar of autoimmune Enbrel entanercept, in India. Intas says that Intracept cuts the cost of treatment to …

    Published on 5/4/2015
  • Pathway Genomics sales and marketing update

    Pathway Genomics Corp., San Diego, Calif. Business: Diagnostic Pathway launched cancer tests ColoTrue and LynchSyndromeTrue. ColoTrue detects pathogenic variants in 15 genes associated with colorectal cancer. …

    Published on 5/4/2015
  • Rosetta Genomics, Admera Health sales and marketing update

    Rosetta Genomics Ltd. (NASDAQ:ROSG), Rehovot, Israel Admera Health, South Plainfield, N.J. Business: Cancer Rosetta launched Admeras laboratory developed test (LDT), OncoGxOne to detects alterations in 64 genes …

    Published on 5/4/2015
  • Dendreon sales and marketing update

    Dendreon Corp. (Pink:DNDNQ), Seattle, Wash. Business: Cancer On March 19, Germans Institute for Quality and Efficiency in Health Care (IQWiG) said in an addendum to a January early benefit assessment that Provenge …

    Published on 4/27/2015
  • Medivation, Astellas sales and marketing update

    Medivation Inc. (NASDAQ:MDVN), San Francisco, Calif. Astellas Pharma Inc. (Tokyo:4503), Tokyo, Japan Business: Cancer Germanys Institute for Quality and Efficiency in Healthcare (IQWiG) said in an assessment that Xtandi…

    Published on 4/27/2015
  • Novo Nordisk sales and marketing update

    Novo Nordisk A/S (CSE:NVO; NYSE:NVO), Bagsvaerd, Denmark Business: Endocrine/Metabolic Novo Nordisk launched Saxenda liraglutide in the U.S. for weight management as an adjunct to diet and exercise in adults with a BMI …

    Published on 4/27/2015
  • Thermo Fisher sales and marketing update

    Thermo Fisher Scientific Inc. (NYSE:TMO), Waltham, Mass. Business: Cancer Thermo Fisher launched its CE-IVD Oncomine Solid Tumour Fusion Transcript Kit in the EU to sequence formalin-fixed, paraffin-embedded (FFPE) …

    Published on 4/27/2015

< Previous   1  2  3  4  5  6  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993